Back to Journals » Therapeutics and Clinical Risk Management » Volume 11
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Real-world analysis of the Celgene Global Drug Safety database: early discontinuation of lenalidomide in patients with myelodysplastic syndromes due to non-serious rash
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
17,522 | Dovepress* | 16,211+ | 1,512 | 17,723 | |
PubMed Central* | 1,311 | 332 | 1,643 | ||
Totals | 17,522 | 1,844 | 19,366 | ||
*Since 4 September 2015 +Since July 2016 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
8 | 1 | 0 | 0 | 3 | 4 |
View citations on PubMed Central and Google Scholar